JP Morgan Chase
AMBI

JP Morgan Chase’s Ambit Biosciences Corp AMBI Stock Holding History

JP Morgan Chase’s Portfolio AMBI Stock Details AMBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-158,053
Closed -$2.43M – 4546
2014
Q3 		$2.43M Buy
+158,053
New +$1.09M ﹤0.01% 2797
2013
Q3 		– Sell
-218,300
Closed -$1.53M – 4554
2013
Q2 		$1.53M Buy
+218,300
New +$1.56M ﹤0.01% 2983

JP Morgan Chase's AMBI Position: Q4 2014 in Review

JP Morgan Chase sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 158,053 shares — an estimated $2.43M sold.

JP Morgan Chase first reported a position in AMBI in Q2 2013 and held it in 2 quarters. The position peaked at $2.43M in Q3 2014. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

  • JP Morgan Chase reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
  • JP Morgan Chase sold 158,053 Ambit Biosciences Corp shares in Q4 2014, an estimated $2.43M.
  • JP Morgan Chase first reported a position in Ambit Biosciences Corp in Q2 2013 and held it in 2 quarters.
  • JP Morgan Chase's Ambit Biosciences Corp position peaked at $2.43M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on JP Morgan Chase's 13F filing for Q4 2014, filed 13 Feb 2015.